UV-induced skin cancer: Similarities - Variations

JDDG - Journal of the German Society of Dermatology

Volumn 3, Issue 7, 2005, Pages 493-503

  Boukamp, Petra ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Basal cell carcinoma; Genetic aberrations; Malignant melanoma; Merkel cell carcinoma; Progression models; Squamous cell carcinoma

Indexed keywords

BASAL CELL CARCINOMA; CARCINOGENESIS; HUMAN; IN VITRO STUDY; KERATINOCYTE; MERKEL CELL TUMOR; NEUROECTODERM TUMOR; RADIATION INJURY; REVIEW; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION;

CARCINOMA, BASAL CELL; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; HUMANS; MELANOMA; NEOPLASMS, RADIATION-INDUCED; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 21744434825     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2005.05037.x     Document Type: Review

References (78)

1. Cleaver JE, Crowley E. UV damage, DNA repair and skin carcinogenesis. Front Biosci 2002; 7: d1024-d1043.
2. Pfister H. Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003; 52-56.
3. Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarre M, de Villiers EM, Filotico R, Boukamp P, Tommasino M. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 2003; 77: 2195-2206.
4. Forslund O, Ly H, Reid C, Higgins G. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003; 149: 64-73.
5. Meyer T, Arndt R, Nindl I, Ulrich C, Christophers E, Stockfleth E. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int 2003; 16: 146-153.
6. Schaffer JV, Bolognia JL. The melanocortin-1 receptor: red hair and beyond. Arch Dermatol 2001; 137: 1477-1485.
7. Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 2003; 3: 559-570.
8. Rohwedder A, Philips B, Malfetano J, Kredentser D, Carlson JA. Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature. Am J Dermatopathol 2002; 24: 230-240.
9. Krasagakis K, Tosca AD. Overview of Merkel cell carcinoma and recent advances in research. Int J Dermatol 2003; 42: 669-676.
10. Popp S, Waltering S, Herbst C, Moll I, Boukamp P. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 2002; 99: 352-360.
11. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-1691.
12. Rubel JR, Milford EL, Abdi R. Cutaneous neoplasms in renal transplant recipients. Eur J Dermatol 2002; 12: 532-535.
13. Sherr CJ. Principles of tumor suppression. Cell 2004; 116: 235-246.
14. Toftgard R. Hedgehog signaling in cancer. Cell Mol Life Sci 2000; 57: 1720-1731.
15. Couve-Privat S, Le Bret M, Traiffort E, Queille S, Coulombe J, Bouadjar B, Avril MF, Ruat M, Sarasin A, Daya-Grosjean L. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients. Cancer Res 2004; 64: 3559-3565.
16. Thomas M, Kalita A, Labrecque S, Pirn D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19: 1092-1100.
17. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998; 393: 229-234.
18. McGregor JM, Harwood CA, Brooks L, Fisher SA, Kelly DA, O'nions J, Young AR, Surentheran T, Breuer J, Millard TP, Lewis CM, Leigh IM, Storey A, Crook T. Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J Invest Dermatol 2002; 119: 84-90.
19. Manson C, Naysmith L, Waterston K, Melton D, Rees J. No association between p53 codon 72 polymorphismus and erythemal response. Investigat Dermatol 2004; 122: 1334-1335.
20. Rees J. P for probability and p for p53. J Invest Dermatol 2003; 121: xii-xiii.
21. Giglia-Mari G, Sarasin A. TP53 mutations in human skin cancers. Hum Mutat 2003; 21: 217-228.
22. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1996; 1: 136-142.
23. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE, Brash, DE. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 1993; 90: 4216-4220.
24. Deppert W, Gohler T, Koga H, Kim E. Mutant p53: "gain of function" through perturbation of nuclear structure and function? J Cell Biochem Suppl 2000; Suppl 35: 115-122.
25. Rivers JK. Is there more than one road to melanoma? Lancet 2004; 363: 728-730.
26. Hayward N. New developments in melanoma genetics. Curr Oncol Rep 2000; 2: 300-306.
27. Bennett DC. Human melanocyte senescence and melanoma susceptibility genes. Oncogene 2003; 22: 3063-3069.
28. Kumar R, Angelini S, Snellman E, Hemminki K. BRAP mutations are common somatic events in melanocytic nevi. J Invest Dermatol 2004; 122: 342-348.
29. Ling G, Persson A, Berne B, Uhlen M, Lundeberg J, Ponten F. Persistent p53 mutations in single cells from normal human skin. Am J Pathol 2001; 159: 1247-1253.
30. Le Pelletier F, Soufir N, de la SP, Janin A, Basset-Seguin N. p53 Patches are not increased in patients with multiple nonmelanoma skin cancers. J Invest Dermatol 2001; 117: 1324-1325.
31. Kanjilal S, Strorn SS, dayman GL, Weber RS, el-Naggar AK, Kapur V, Cummings KK, Hill LA, Spitz MR, Kripke ML. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res 1995; 55: 3604-3609.
32. Rehman I, Quinn AG, Healy E, Rees JL. High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease. Lancet 1994; 344: 788-789.
33. Rehman I, Takata M, Wu YY, Rees JL. Genetic change in actinic keratoses. Oncogene 1996; 12: 2483-2490.
34. Jin Y, Jin C, Salemark L, Wennerberg J, Persson B, Jonsson N. Clonal chromosome abnormalities in premalignant lesions of the skin. Cancer Genet Cytogenet 2002; 136: 48-52.
35. Kushida Y, Mild H, Ohmori M. Loss of heterozygosity in actinic keratosis, squamous cell carcinoma and sun-exposed normal-appearing skin in Japanese: difference between Japanese and Caucasians. Cancer Lett 1999; 140: 169-175.
36. Hurt MA. Keratoacanthoma vs. squamous cell carcinoma in contrast with keratoacanthoma is squamous cell carcinoma. J Cutan Pathol 2004; 31: 291-292.
37. Waring AJ, Takata M, Rehman I, Rees JL. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br J Cancer 1996; 73: 649-653.
38. Jin Y, Martins C, Salemark L, Persson B, Jin C, Miranda J, Fonseca I, Jonsson N. Nonrandom karyotypic features in basal cell carcinomas of the skin. Cancer Genet Cytogenet 2001; 131: 109-119.
39. Quinn AG, Sikkink S, Rees JL. Delineation of two distinct deleted regions on chromosome 9 in human non-melanoma skin cancers. Genes Chromosomes Cancer 1994; 11: 222-225.
40. Jin Y, Martins C, Jin C, Salemark L, Jonsson N, Persson B, Roque L, Fonseca I, Wennerberg J. Nonrandom karyotypic features in squamous cell carcinomas of the skin. Genes Chromosomes Cancer 1999; 26: 295-303.
41. Ashton KJ, Weinstein SR, Maguire DJ, Griffiths LR. Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization. Arch Dermatol 2003; 139: 876-882.
42. Speicher MR, Gwyn BS, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 1996; 12: 368-375.
43. Hoglund M, Gisselsson D, Hansen GB, White VA, Sail T, Mitelman F, Horsman D. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer 2004; 108: 57-65.
44. Ross DA, Wilson GD. Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma. Br J Surg 1998; 85: 46-51.
45. Kraehn GM, Utikal J, Udart M, Greulich KM, Bezold G, Kaskel P, Leiter U, Peter RU. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases. Br J Cancer 2001; 84: 72-79.
46. Tuveson DA, Weber BL, Herlyn M. BRAF as a potential therapeutic target in melanoma and other malignancies. Cancer Cell 2003; 4: 95-98.
47. Li G, Schaider H, Satyamoorthy K, Hanakawa Y, Hashimoto K, Herlyn M. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene 2001; 20: 8125-8135.
48. Wu H, Goel V, Haluska FG. PTEN signalling pathways in melanoma. Oncogene 2003; 22: 3113-3122.
49. Van Gele M, Van Roy N, Ronan SG, Messiaen L, Vandesompele J, Geerts ML, Naeyaert JM, Blennow E, Bar-Am I, Das Gupta TK, van der Drift P, Versteeg R, Leonard JH, Speleman F. Molecular analysis of Ip36 breakpoints in two Merkel cell carcinomas. Genes Chromosomes Cancer 1998; 23: 67-71.
50. Van Gele M, Speleman F, Vandesompele J, Van Roy N, Leonard JH. Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization. Cancer Res 1998; 58: 1503-1508.
51. Hoglund M, Jin C, Gisselsson D, Hansen GB, Mitelman F, Mertens F. Statistical analyses of karyotypic complexity in head and neck squamous cell carcinoma. Cancer Genet Cytogenet 2004; 150: 1-8.
52. Masters JR, Palsson B (eds). Human Cell Culture: Volume II Cancer Cell Lines Part 2 1999: 400p.
53. Proby CM, Purdie KJ, Sexton CJ, Purkis P, Navsaria HA, Stables JN, Leigh IM. Spontaneous keratinocyte cell lines representing early and advanced stages of malignant transformation of the epidermis. Exp Dermatol 2000; 9: 104-117.
54. Popp S, Waltering S, Holtgreve-Grez H, Jauch A, Proby C, Leigh IM, Boukamp P. Genetic characterization of a human skin carcinoma progression model: from primary tumor to metastasis. J Invest Dermatol 2000; 115: 1095-1103.
55. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-771.
56. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N, Rogan EM. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 1993; 14: 833-839.
57. Boukamp P, Popp S, Aitmeyer S, Hulsen A, Fasching C, Cremer T, Fusenig NE. Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT. Genes Chromosomes Cancer 1997; 19: 201-214.
58. Fusenig NE, Boukamp P. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog 1998; 23: 144-158.
59. Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA, Fusenig NE. c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res 1990; 50: 2840-2847.
60. Boukamp P, Peter W, Pascheberg U, Altmeier S, Fasching C, Stanbridge EJ, Fusenig NE. Step-wise progression in human skin Carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss. Oncogene 1995; 11: 961-969.
61. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A 1990; 87: 6624-6628.
62. Bleuel K, Popp S, Fusenig NE, Stanbridge EJ, Boukamp P. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc Natl Acad Sci USA 1999; 96: 2065-2070.
63. Boukamp P, Popp S, Bleuel K, Tomakidi E, Burkle A, Fusenig NE. Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature. Oncogene 1999; 18: 5638-5645.
64. Ashman JN, Patmore HS, Condon LT, Cawkwell L, Stafford ND, Greenman J. Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridization. Br J Cancer 2003; 89: 864-869.
65. Poppe B, Vandesompele J, Schoch C, Lindvall C, Mrozek K, Bloomfield CD, Beverloo HB, Michaux L, Dastugue N, Kerens C, Yigit N, De Paepe A, Hagemeijer A, Speleman F. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 2004; 103: 229-235.
66. Aaronson SA. Growth factors and cancer. Science 1991; 254: 1146-1153.
67. Shih IM, Herlyn M. Autocrine and paracrine roles for growth factors in melanoma. In Vivo 1994; 8: 113-123.
68. Obermueller E, Vosseler S, Fusenig NE, Mueller MM. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res 2004; 64: 7801-7812.
69. Mueller MM, Peter W, Mappes M, Huelsen A, Steinbauer H, Boukamp P, Vaccariello M, Garlick J, Fusenig NE. Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Am J Pathol 2001; 159: 1567-1579.
70. Mudgil AV, Segal N, Andriani F, Wang Y, Fusenig NE, Garlick JA. Ultraviolet B irradiation induces expansion of intraepithelial tumor cells in a tissue model of early cancer progression. J Invest Dermatol 2003; 121: 191-197.
71. Billings SD, Southall MD, Li T, Cook PW, Baldridge L, Moores WB, Spandau DF, Foley JG, Travers JB. Amphiregulin overexpression results in rapidly growing keratinocytic tumors: an in vivo xenograft model of keratoacanthoma. Am J Pathol 2003; 163: 2451-2458.
72. Guzman E, Langowski JL, Owen-Schaub L. Mad dogs, Englishmen and apoptosis: the role of cell death in UV-induced skin cancer. Apoptosis 2003; 8: 315-325.
73. Backvall H, Wassberg C, Berne B, Ponten F. Similar UV responses are seen in a skin organ culture as in human skin in vivo. Exp Dermatol 2002; 11: 349-356.
74. Gambardella L, Barrandon Y. The multifaceted adult epidermal stem cell. Curr Opin Cell Biol 2003; 15: 771-777.
75. Bickenbach JR, Dunnwald M. Epidermal stem cells: characteristics and use in tissue engineering and gene therapy. Adv Dermatol 2000; 16: 159-183.
76. Cerezo A, Stark HJ, Moshir S, Boukamp P. Constitutive overexpression of human telomerase reverse transcriptase but not c-myc blocks terminal differentiation in human HaCaT skin keratinocytes. J Invest Dermatol 2003; 121: 110-119.
77. Tabata H, Nagano T, Ray AJ, Flanagan N, Birch-MacHin MA, Rees JL. Low frequency of genetic change in p53 immunopositive clones in human epidermis. J Invest Dermatol 1999; 113: 972-976.
78. Cairns J. Mutation selection and the natural history of cancer. Nature 1975; 255: 197-200.